Zortress Alternatives Compared
| Zortress (everolimus) | Lutathera (lutetium lu 177 dotatate) | Lanreotide |
|
|---|
| Zortress (everolimus) | Lutathera (lutetium lu 177 dotatate) | Lanreotide |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Neuroendocrine Tumors, Organ Transplant - Rejection Prophylaxis. Zortress may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Neuroendocrine Tumors. Lutathera may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Neuroendocrine Tumors, Carcinoid Syndrome, Acromegaly. Lanreotide may also be used for purposes not listed in this medication guide. |
Related suggestions Neuroendocrine Tumors
Popular comparisons
|
|||||||||||||||||||||||
| More about Zortress (everolimus) | More about Lutathera (lutetium lu 177 dotatate) | More about Lanreotide | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Zortress has an average rating of 10.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Lutathera has an average rating of 9.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Lanreotide has an average rating of 8.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Zortress side effects |
View all Lutathera side effects |
View all Lanreotide side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
||||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Zortress prices |
View all Lutathera prices |
View all Lanreotide prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other everolimus brands include: Afinitor, Afinitor Disperz, Torpenz |
N/A |
Somatuline Depot | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
35 hours |
71 hours |
720 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 557 drugs are known to interact with Zortress:
|
A total of 241 drugs are known to interact with Lutathera:
|
A total of 165 drugs are known to interact with Lanreotide:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
April 20, 2010 |
N/A |
N/A |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Cabometyx
Cabometyx is used to treat advanced kidney cancer, liver cancer, thyroid cancer, and pancreatic and ...
Afinitor
Afinitor prevents the growth of cancer cells and is used to treat advanced kidney cancer. Learn ...
Lutathera
Lutathera is a targeted radiotherapy used for gastroenteropancreatic neuroendocrine tumors ...
Cometriq
Cometriq (cabozantinib) is used to treat thyroid cancer that has spread to other parts of the body ...
Somatuline Depot
Somatuline Depot is used as a long-term treatment for acromegaly. Learn about side effects ...
Lutetium lu 177 dotatate
Lutetium Lu 177 Dotatate (Lutathera) is a targeted radiotherapy used for gastroenteropancreatic ...
Cabozantinib
Cabozantinib is used for hepatocellular carcinoma, neuroendocrine tumors, renal cell carcinoma ...
Lanreotide
Lanreotide (Somatuline Depot) is an injectable medication containing a man-made (synthetic ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.